Effects of Omega-3 Supplementation on the Cytokine and Lipid Profiles in Patients With Chronic Chagas Cardiomyopathy

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

December 31, 2015

Conditions
Chagas Cardiomyopathy
Interventions
DIETARY_SUPPLEMENT

Omega-3

The group omega-3 receives 5 capsules / day, each capsule containing 1100mg of lipids, and 600 mg of omega-3, 3g of omega-3 per day (1.8 g EPA and 1.2 g DHA) for a period of 8 weeks.

DIETARY_SUPPLEMENT

Placebo Comparator

The group placebo receives 5 capsules / day of corn oil containing 1100mg each, for a period of 8 weeks.

Trial Locations (1)

rj"

Evandro Chagas Institute of Clinical Research, Rio de Janeiro

All Listed Sponsors
collaborator

Andrea Silvestre de Sousa, MD PhD

UNKNOWN

collaborator

Alejandro Marcel Hasslocher, MD MSc PhD student

UNKNOWN

collaborator

Andrea Pereira de Souza, PhD

UNKNOWN

collaborator

Claudia Santos de Aguiar Cardoso, MSc

UNKNOWN

collaborator

Patricia Dias de Brito, PhD

UNKNOWN

collaborator

Pedro Emmanuel Alvarenga Americano do Brasil, MD PhD

UNKNOWN

collaborator

Roberta Olmo Pinheiro, PhD

UNKNOWN

collaborator

Roberto Magalhães Saraiva, MD PhD

UNKNOWN

collaborator

Sergio Salles Xavier, MD PhD

UNKNOWN

collaborator

Paula Simplicio da Silva, MSc PhD student

UNKNOWN

lead

Evandro Chagas Institute of Clinical Research

OTHER

NCT01863576 - Effects of Omega-3 Supplementation on the Cytokine and Lipid Profiles in Patients With Chronic Chagas Cardiomyopathy | Biotech Hunter | Biotech Hunter